首页> 外国专利> Molecules of nucleic acids coding a dextran-saccharase catalysing the synthesis of dextran having alpha-1,2 osidic branching

Molecules of nucleic acids coding a dextran-saccharase catalysing the synthesis of dextran having alpha-1,2 osidic branching

机译:编码葡聚糖-蔗糖酶的核酸分子催化具有α-1,2osidic分支的葡聚糖的合成

摘要

New isolated polypeptides (I), with glycosyl transferase activity suitable for producing dextrans having alpha (1-2) branches from sucrose, alpha -fluoroglucose, p-nitrophenyl-alpha -D-glucopyranoside, alpha -D-glucopyranoside-alpha -D-sorbopyranoside or alpha -D-galactopyranosyl-sucrose, and at least one glucan bonding domain (GBD) and a catalytic domain (CD) downstream of the GBD, are new. Independent claims are also included for: (1) an isolated nucleic acid encoding (I), having at least one nucleotide sequence encoding a CD and with at least 50% (preferably at least 80%) homology with a sequence of 2568 bases given in the specification (S3), located at 3' relative to a sequence encoding a GBD; (2) an expression vector containing a nucleic acid as in (1) (preferably under the control of sequences allowing expression in prokaryotic or eukaryotic cells); (3) host cells transformed by a nucleic acid as in (1) or a vector as in (2); (4) methods for the production of (I) (specifically dextran saccharases); (5) glycosyl transferases forming at least 30% alpha (1-2) bonds obtained as in (4); (6) the production of a dextran saccharase (I'), suitable for forming oligosides or dextrans having more than 30% alpha (1-2) bonds, involving modification of a fully defined sequence of 8506 bases given in the specification (S4) by addition, deletion and mutation, such that when the reading frame is not modified, the following aminoacids are retained: W in positions 425 and 2122 (encoded by TGG in positions 1273 and 6364), E in positions 430, 565, 2127 and 2248 (encoded by GAA in positions 1288, 1693, 6379 and 6742), D in positions 487, 489, 527, 638, 2170, 2172, 2210 and 2322 (encoded by GAT in positions 1459, 1465, 1579, 1912, 6508 and 6628), H in positions 637 and 2321 (encoded by CAT in position 1909 and CAC in position 6961) and Q in positions 1019 and 2694 (encoded by CAA in position 3055 and CAG in position 8080); and (7) the production of a glycosyl transferase (I''), suitable for forming oligosides or dextrans having more than 30% alpha (1-2) bonds, by random mutation of (S4), forming a library of variants, expressing these modified sequences in a suitable host cell, screening the hosts for expression of (I'') and isolating the improved genes. ACTIVITY : Cytostatic; dermatological; antiseborrheic. No biological data is given. MECHANISM OF ACTION : None given.
机译:具有糖基转移酶活性的新分离的多肽(I),其适于由蔗糖,α-氟葡萄糖,对硝基苯基-α-D-吡喃葡萄糖苷,α-D-吡喃葡萄糖苷-α-D-产生具有α(1-2)分支的右旋糖酐山梨吡喃糖苷或α-D-吡喃半乳糖基蔗糖,以及GBD下游的至少一个葡聚糖键合域(GBD)和催化域(CD)是新的。还包括以下方面的独立权利要求:(1)编码(I)的分离的核酸,其具有至少一个编码CD的核苷酸序列,并且与在此给出的2568个碱基具有至少50%(优选至少80%)的同源性。规范(S3),相对于编码GBD的序列位于3'; (2)一种表达载体,其含有如(1)中所述的核酸(优选在允许在原核或真核细胞中表达的序列的控制下); (3)用(1)的核酸或(2)的载体转化的宿主细胞。 (4)生产(Ⅰ)(特别是右旋糖酐葡聚糖酶)的方法; (5)通过(4)获得的形成至少30%的α(1-2)键的糖基转移酶; (6)葡聚糖糖酶(I')的制备,适用于形成具有30%以上的α(1-2)键的寡糖或葡聚糖,涉及对说明书(S4)中给出的8506个碱基的完整定义序列进行修饰通过添加,缺失和突变,使得当不修饰阅读框时,保留以下氨基酸:425位和2122位的W(由TGG在1273位和6364位编码),E位在430、565、2127和2248位(由GAA在1288、1693、6379和6742位置编码),D在487、489、527、638、2170、2172、2210和2322位置(由GAT在1459、1465、1579、1912、6508和6628位置编码) ),位置637和2321的H(由CAT编码为1909,CAC编码为6961)和Q为位置1019和2694(由CAA编码为3055,CAG编码为8080); (7)通过随机突变(S4)形成适于形成具有30%以上α(1-2)键的寡糖或葡聚糖的糖基转移酶(I''),形成变体文库,这些修饰的序列在合适的宿主细胞中,筛选宿主表达(I'')并分离改良的基因。活动:细胞抑制;皮肤;抗脂溢性。没有给出生物学数据。作用机理:未给出。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号